The point-of-care opioid testing market is anticipated to reach a valuation of US$ 450.9 million by 2023. The market is anticipated to grow at a 4.9% CAGR over the course of the forecast period, reaching US$ 725.1 million by 2033. The growing opioid epidemic, growing public awareness of drug abuse, and the demand for effective testing techniques …